Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C-Reference-Cited by-同舟云学术

Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C

Published:2011 Issue:3 Volume:115 Page:263-269
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Sugiyama Masaya,Tanaka Yasuhito,Nakanishi Makoto,Mizokami Masashi

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference35 articles.

1. 1 Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36:S21–S29.

2. 3 Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol. 2007;21:447–451.

3. The Natural History of Hepatitis C Virus Infection

4. 5 Aborsangaya KB, Dembinski I, Khatkar S, Alphonse MP, Nickerson P, Rempel JD. Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. Hepatology. 2007;45:623–630.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia;Archives of Biological Sciences;2023

2. RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin;Archives of Biological Sciences;2022

3. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges;Medicine;2016-12

4. Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1;Clinics and Research in Hepatology and Gastroenterology;2015-12

5. Resistance to hepatitis C virus: potential genetic and immunological determinants;The Lancet Infectious Diseases;2015-04